Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Age at Diagnosis
8%
Amsterdam
8%
Cancer Center
8%
Cancer Predisposition
100%
Center Experience
8%
Childhood Cancer
8%
Children with Cancer
33%
Clinical Geneticist
8%
Clinical Genetics
8%
Common Cancers
8%
Diagnostic Approach
8%
Diagnostic Value
8%
Down Syndrome
8%
Driven Approach
25%
Dutch
8%
Family History
8%
Gene Sequencing
16%
Genetic Testing
25%
Genotype-first Approach
8%
Hematologic Neoplasms
8%
Median Range
8%
National Cohort
100%
Neoplasms
100%
Neoplasms/diagnosis
8%
Netherlands
16%
Neurofibromatosis Type 1 (NF-1)
8%
Neurofibromatosis Type I
8%
New Diagnosis
8%
Next-generation Sequencing
8%
Patient Median
8%
Pediatric Oncologists
8%
Pediatric Oncology
8%
Pediatric Ophthalmologists
8%
Pediatric Patients
8%
Retinoblastoma
8%
Retrospective Cohort Study
8%
Routine Diagnostics
8%
Solid Tumors
8%
Specific Types
8%
Treatment Centers
8%
Nursing and Health Professions
Cancer Center
8%
Cancer Susceptibility
100%
Childhood Cancer
16%
Cohort Analysis
16%
Data Processing
8%
Diagnostic Value
8%
Down Syndrome
8%
Family History
8%
Gene Sequence
16%
Genetic Screening
25%
Malignant Neoplasm
25%
Medical Geneticist
8%
Neoplasm
100%
Neurofibromatosis Type 1
8%
Next-Generation Sequencing
8%
Ophthalmologist
8%
Patient Referral
8%
Pediatric Oncologist
8%
Pediatrics Patient
8%
Prevalence
8%
Retinoblastoma
8%
Solid Malignant Neoplasm
8%
Syndrome
100%
Treatment Centre
8%
Medicine and Dentistry
Cancer Susceptibility
100%
Childhood Cancer
16%
Cohort Analysis
8%
Down Syndrome
8%
Family History
8%
Gene Sequence
16%
Genetic Screening
25%
Malignant Neoplasm
33%
Neoplasm
100%
Neurofibromatosis Type I
8%
Next Generation Sequencing
8%
Patient Referral
8%
Pediatric Oncologist
8%
Pediatrics Patient
8%
Prevalence
8%
Retinoblastoma
8%
Retrospective Cohort Study
8%
Solid Malignant Neoplasm
8%